Carlyle Group in talks to acquire Granules India


According to reports by CNBC TV18, the investment firm Carlyle Group is in advanced stages for acquisition of Granules India for around $1 billion. Carlyle is likely to buy promoter shares of Granules India. Carlyle recently bought a small stake in Piramal Pharma and acquired global veterinary giant Sequent Scientists. However Granules India stayed muted to CNBC TV18 comment.  

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More